Quantitative PCR for early detection of human cytomegalovirus end-organ disease in immunocompetent host: A retrospective single-center study
Journal of Infection and Public Health · 2024
DOI: 10.1016/j.jiph.2024.102542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Cheon-Hoo Jun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Cytomegalovirus, Viremia, Real-Time Polymerase Chain Reaction. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Tissue-invasive end-organ disease (EOD) caused by cytomegalovirus (CMV) is less frequently reported in immunocompetent patients compared to immunocompromised patients. In this study, we investigated the association between CMV viremia and CMV end-organ disease in immunocompetent patients. METHODS: Adult patients (≥18 years old) with CMV viremia were screened from January 2010 to June 2022. The primary outcome was the presence of CMV EOD. Risk factors associated with CMV EOD were analyzed, and a receiver operating characteristic curve was plotted to determine the most accurate cutoff value of the CMV titer for the prediction of CMV EOD. RESULTS: Among the 106 immunocompetent patients with CMV viremia, 31 exhibited CMV EOD. Gastrointestinal tract disease was the most common. The log10 value of the CMV titer was significantly associated with the occurrence of CMV EOD in immunocompetent patients with CMV viremia. The optimal cut-off CMV titer for the prediction of CMV EOD was 749 IU/mL. CONCLUSIONS: Our study suggests the potential association between high CMV titers and the development of CMV end-organ diseases and describes the diagnostic performance and utility of quantitative PCR as a surrogate marker for predicting the occurrence of CMV EOD in immunocompetent patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
- Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
- Department of Laboratory Medicine and Genetics, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.
- Department of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea. Electronic address: yumi.wi@samsung.com.
Zitieren
APA
Jun, C. H., Kim, S. H., Kim, J., Kim, K. M., Lee, J. W., Kong, S. M., Kwak, J., Kwan, B. S., Cho, H. K., Park, K. J., Kim, H. T., & Wi, Y. M. (2024). Quantitative PCR for early detection of human cytomegalovirus end-organ disease in immunocompetent host: A retrospective single-center study. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.102542
Vancouver
Jun CH, Kim SH, Kim J, Kim KM, Lee JW, Kong SM, et al. Quantitative PCR for early detection of human cytomegalovirus end-organ disease in immunocompetent host: A retrospective single-center study. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.102542
BibTeX
@article{Jun2024,
author = {Jun, Cheon-Hoo and Kim, Si-Ho and Kim, Junyoung and Kim, Kwang Min and Lee, Jung Won and Kong, Sung Min and Kwak, Jiyeong and Kwan, Byung Soo and Cho, Hyun Kyu and Park, Kyoung-Jin and Kim, Hyoung Tae and Wi, Yu Mi},
title = {Quantitative PCR for early detection of human cytomegalovirus end-organ disease in immunocompetent host: A retrospective single-center study},
journal = {Journal of Infection and Public Health},
year = {2024},
doi = {10.1016/j.jiph.2024.102542}
}
EUVIMED